Zusammenfassung der Publikationen

  n Impact Faktor 2015
Originalarbeiten 32 89,998
Übersichtsarbeiten 11 18,625
Summe 43 108,623
  n Impact Faktor 2015
Originalarbeiten 17 26,402
Übersichtsarbeiten 6 3,977
Summe 23 30,379

Publications Seite 1 von 4


57. Blood Rheology during normal Pregnancy
2018 in press. Clin Hemorheol Microcirc. 2.215
P. Tsikouras3, B. Niesigk, G.-F. v. Tempelhoff1, W. Rath, O. Schelkunov, R Csorba

56. Epidemiology, Risk Factors and Risk Stratification of Venous Thromboembolism in Pregnancy and the Puerperium
2017;221:61-174. Z Geburtshilfe Neonatol. 0,47
Tsikouras P, von Tempelhoff GF, Rath W.

55. Inherited thrombophilia and reproductive disorders.
2016;17:45-50. J Turk Ger Gynecol Assoc.
SA. Liatsikos, P. Tsikouras, B. Manav, R. Csorba, G.-F.v. Tempelhoff, G. Galazios.

54. Primary ovarian carcinoid tumors: effective management of a rare and challenging condition.
2016;71:214-5. Minerva Chir.
P Tsikouras, M Dimitraki,S Zervoudis, B Manav,A Liberis,G Galazios, G.-F.v. Tempelhoff.

53. Pharmacological Thromboprophylaxis during Pregnancy and the Puerperium: Recommendations from Current Guidelines and their Critical Comparison.
2016;220:95-105. Z Geburtshilfe Neonatol. 0.483
W Rath , P Tsikouras , G.-F.v. Tempelhoff.

52. Correlation between blood rheological properties and Red Blood Cell Indices (MCH, MCV, MCHC) in healthy women.
2016;62:45-54. Clin Hemorheol Microcirc. . 2.215
G.-F.v. Tempelhoff , P Tsikouras, W Rath, E Velten , R Csorba.

51. Features of Polycystic Ovary Syndrome in adolescence.
2015;8:291-6. J Med Life. 0.83
P. Tsikouras, L. Spyros, B. Manav,S. Zervoudis, C. Poiana, T. Nikolaos, P. Petros, M. Dimitraki,C. Koukouli,G. Galazios, G.-F.v. Tempelhoff.

50. Thrombelastometric results and platelet function during pregnancy in women receiving low molecular weight heparin with a history of recurrent/late abortion - A retrospective analysis.
2015;61:99-110. Clin Hemorheol Microcirc. 2.215
G.-F.v. Tempelhoff, Schelkunov O, Demirhan A, Tsikouras P, Rath W, Velten E, Csorba R.

49. Rheological, Hemostaseological changes during Immune therapy for prevention of HELLP-Syndrome in a patient with elevated Phospholipid antibodies.
2015; 60:123-31. Clin Hemorheol Microcirc. 2.215
G.-F.v. Tempelhoff , Tsikouras P, Rath W, Velten E, Csorba R.

48. Rheologic results and their correlation to hemostatic changes in patients with moderate and severe preeclampsia: An observational cross-sectional study.
2015; 59:1-15. Clin Hemorheol Microcirc. 3.398
A.A. Soliman, R. Csorba, A. Yilmaz, P. Tsikouras, G.-F.v. Tempelhoff.

47. Correlation of rheological parameters in maternal and fetal blood.
2014; 25:1-8. J of Matern-Fet Neonat Med. 1.518
R Csorba, AA Soliman, Wieg C, Tsikouras P, Harnack H, Rath W, G.-F.v. Tempelhoff.

46. Uterine prolapse in pregnancy: risk factors, complications and management
2014;27:297-302. J Matern Fetal Neonatal Med. 1.518
P. Tsikouras,A. Dafopoulos, N. Vrachnis,Z. Iliodromiti, S. Bouchlariotou, P. Pinidis, N. Tsagias, V. Liberis, G. Galazios, G.-F.v. Tempelhoff

45. Antiphopholipid antibodies and functional activated protein C resistance in breast cancer patients during anthracycline-based chemotherapy administered through an intravenous port-catheter device.
2014; 20:338-40. Clin Appl Thromb Hemost. 1.016
A.A. Soliman, R. Csorba, A. Ullrich, P. Tsikouras, W. Rath, G.-F.v. Tempelhoff.

44. The contribution of catumaxomab in the treatment of malignant ascites in patients with ovarian cancer: a review of the literature.
2013;288:581-5. Arch Gynecol Obstet. 1.68
P. Tsikouras, N. Tsagias, P. Pinidis, R. Csorba, N. Vrachnis, A. Dafopoulos, S. Bouchlariotou, A. Liberis, A.T. Teichmann, G.-F. v. Tempelhoff.

43. Rheological parameters in the umbilical cord blood in moderate and severe forms of preeclampsia.
2013; 55:391-401. Clin Hemorheol Microcirc. 0
R. Csorba, A. Yimaz, P. Tsikouras, C. Wieg, A.T. Teichmann, G.-F.v. Tempelhoff.


Copyright © 2024 - KIWU - von Tempelhoff

Wir benutzen Cookies

Wir nutzen Cookies auf unserer Website. Einige von ihnen sind essenziell für den Betrieb der Seite, während andere uns helfen, diese Website und die Nutzererfahrung zu verbessern (Tracking Cookies). Sie können selbst entscheiden, ob Sie die Cookies zulassen möchten. Bitte beachten Sie, dass bei einer Ablehnung womöglich nicht mehr alle Funktionalitäten der Seite zur Verfügung stehen.